Ascendiant Capital Markets Has Lowered Expectations for Outlook Therapeutics (NASDAQ:OTLK) Stock Price
Outlook Therapeutics (NASDAQ:OTLK – Get Free Report) had its target price dropped by research analysts at Ascendiant Capital Markets from $24.00 to $21.00 in a research note issued on Friday,Benzinga reports. The brokerage currently has a “buy” rating on the stock. Several other analysts also recently weighed in on OTLK. HC Wainwright lowered their target […]
Outlook Therapeutics (NASDAQ:OTLK – Get Free Report) had its target price dropped by research analysts at Ascendiant Capital Markets from $24.00 to $21.00 in a research note issued on Friday,Benzinga reports. The brokerage currently has a “buy” rating on the stock. Several other analysts also recently weighed in on OTLK. HC Wainwright lowered their target […]
